Propargyl-PEG4-tetra-Ac-beta-D-galactose
Code | Size | Price |
---|
TAR-T16632-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T16632-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Propargyl-PEG4-tetra-Ac-beta-D-galactose is a PEGylated proteolysis-targeting chimera (PROTAC) linker utilized for PROTAC synthesis[1].
CAS:
1397682-61-9
Formula:
C25H38O14
Molecular Weight:
562.56
Purity:
0.98
SMILES:
O(C(C)=O)[C@@H]1[C@@H](OC(C)=O)[C@H](OCCOCCOCCOCCOCC#C)O[C@H](COC(C)=O)[C@@H]1OC(C)=O
References
An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562